Comparison Between the Assessment of Anxious and Depressive Symptomology

Completed

• Conditions: End Stage Disease

• Registration Number: NCT04148924
• Lead Sponsor: Hospices Civils de Lyon

Brief Summary

In palliative care, anxiety and depression in advanced cancer are under evaluated, under diagnosed and therefore under treated. 5 to 30% of patients present anxious and depressive disorders.

Physical symptoms are easy to assess. But in palliative care it is important to take care of moral suffering.

However, evaluation and management of patient's anxiety and depressive symptoms are difficult for physicians and caregivers.

The investigators would like to specifically compare the patient's evaluation of anxious and depressive symptomatology in palliative care with the evaluation by the physician, the nurse and the caregiver.

Then the investigators will try to collect the caregivers's difficulties in the management of anxious and depressive symptoms.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-10-31
• Study First Submitted QC: 2019-10-31
• Study First Posted: 2019-11-04
• Study Start: 2019-11-15
• Primary Completion: 2020-11-13
• Study Completion: 2020-11-13
• Status Verified: 2021-07
• Last Update Submitted: 2021-07-26
• Last Update Posted: 2021-07-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients :

• Adult patients (18 years and over)
• Advanced cancer stage
• Patients hospitalized less than 72 hours in Lyon Sud palliative care unit
• Sufficient general conditions to complete survey
• Absence of cognitive disorders
• Agreement to participate at the study

Medical Staff:

• Working full time or part time in the USP or the PMSC of CHLS

Exclusion Criteria

Patients :

• Minor patients
• Patients hospitalized more than 72 hours in Lyon Sud palliative care unit
• Presence of cognitive disorders
• Alteration of general conditions
• Refusal to participate at the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison of the anxious and depressive symptomatology of hospitalized patients in palliative care unit (USP) evaluated on the one hand by the patient himself and on the other hand, in hetero evaluation, by caregivers.	72 hours	The Edmonton Symptom Assessment Scale (ESAS) will be used for assess anxiety and depression intensity. The ESAS is a self-reported outcome tool assessing the intensity of nine symptoms (pain, tiredness, nausea, depressive mood, anxiety, drowsiness, lack of appetite, wellbeing, and breathlessness). Intensity is rated using 10-point Likert-scales from "no-symptom" (scored 0) to "worst possible symptom" (scored 10); The difference of evaluation for anxiety and depressive symptoms is considere significant when there are two points and more between ESAS patient's and ESAS caregivers'.

Trial Locations

Locations (1)

Hôpital Lyon Sud; 🇫🇷 Pierre-Bénite, France